Back
Relay Therapeutics Quote, Financials, Valuation and Earnings
Sell
36
RLAY
Relay Therapeutics
Last Price:
6.64
Seasonality Move:
11.86%
7 Day Trial
ALL ACCESS PASS
$
7
Relay Therapeutics Price Quote
$6.64
Relay Therapeutics Key Stats
Sell
36
Relay Therapeutics (RLAY)
is a Sell
Day range:
$6.33 - $6.72
52-week range:
$5.70 - $13.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
23.47
P/B ratio:
1.18%
Volume:
1.5M
Avg. volume:
1.2M
1-year change:
-35.91%
Market cap:
$881.4M
Revenue:
$25.5M
EPS:
$-2.64
How Much Does Relay Therapeutics Make?
-
How Much Are Relay Therapeutics's Sales Annually?
RLAY Revenues are $25.5M -
How Much Profit Does Relay Therapeutics's Make A Year?
RLAY net income is -$342M
Is Relay Therapeutics Growing As A Company?
-
What Is Relay Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 43.28% -
What Is Relay Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Relay Therapeutics Stock Price Performance
-
Did Relay Therapeutics Stock Go Up Last Month?
Relay Therapeutics share price went up by 6.92% last month -
Did RLAY's Share Price Rise Over The Last Year?
RLAY share price fell by -35.91% over the past 1 year
What Is Relay Therapeutics 52-Week High & Low?
-
What Is Relay Therapeutics’s 52-Week High Share Price?
Relay Therapeutics has traded as high as $13.32 over the past 52 weeks -
What Is Relay Therapeutics’s 52-Week Low Share Price?
Relay Therapeutics has traded as low as $5.70 over the past 52 weeks
Relay Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Relay Therapeutics?
-
How Much Debt Does Relay Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Relay Therapeutics Have?
Cash and short term investments quarterly total is $749.6M -
What Is Relay Therapeutics’s Book Value Per Share?
Book value per share is 5.64
Is Relay Therapeutics Cash Flow Positive?
-
What Is RLAY Cash Flow From Operations?
Cash flow from operations (TTM) is -$283.5M -
What Is Relay Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $82.4M -
What Is Relay Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $192.9M
Relay Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
RLAY return on invested capital is -41.45% -
What Is Relay Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -35.84% -
What Is RLAY Return On Equity?
ROE is a measure of profitability and is -41.45%
Relay Therapeutics Earnings Date & Stock Price
-
What Is Relay Therapeutics's Stock Price Today?
A single share of RLAY can be purchased today for 6.64 -
What Is Relay Therapeutics’s Stock Symbol?
Relay Therapeutics trades on the nasdaq under the ticker symbol: RLAY -
When Is Relay Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Relay Therapeutics is scheduled on August 8, 2024 -
When Is RLAY's next ex-dividend date?
Relay Therapeutics's next ex-dividend date is May 20, 2024 -
How To Buy Relay Therapeutics Stock?
You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Relay Therapeutics Competitors
-
Who Are Relay Therapeutics's Competitors?
Below is a list of companies who compete with Relay Therapeutics or are related in some way:
Relay Therapeutics Dividend Yield
Data Unavailable
Relay Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 9.93% |
| Revenue: | 4327.88% | 9073.16% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 21.96 |
| Upside from Last Price: | 230.78% |